Fosfomycin in the treatment of extended spectrum beta-lactamaseproducing Enterobacteriaceae- related urinary tract infections

TUMTURK A., Tonyali S., TEKCE A. Y. T., ISIKAY L., CIME H.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.13, sa.1, ss.73-76, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3855/jidc.10658
  • Dergi Adı: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.73-76
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Introduction: We aimed to demonstrate if fosfomycin tromethamine (FT) treatment could be the treatment of choice in ESBL-producing Enterobacteriaceae strains as an alternative to carbapenem particularly in patients who we would like to treat on an outpatient basis.